Incorporating New Diabetes Treatments: Rx for Therapeutic Inertia

Activity Details
  • Credit Amounts:
  • Cost: Free
  • Release: Jun 15, 2016
  • Expires: Jun 15, 2018
  • Average User Rating:
    ( Ratings)

Faculty

Needs Statement

This two part educational series is meant to build clinician knowledge and competence about the best practice for managing Type II Diabetes as related to prescribing non-insulin as well as insulin therapies. These utility driven modules are designed to provide tips and algorithms that the primary care clinician can use in the clinic right away. These modules have been developed as part of the BMC Portfolio Program's Performance Improvement CME activity on Diabetes Management, but has been made available as a public resource. 

  • Part 1 - Non-insulin Therapies - 30 minutes
  • Part 2 - Insulin - 30 minutes

According to the Center for Disease Control and Prevention (CDC), the diabetes epidemic continues to rise among the United States population. An individual with diabetes has twofold the risk of death compared to someone without diabetes. Diabetes can lead to kidney failure, non-traumatic lower-limb amputations, and new cases of blindness among adults. Diabetes is also a major cause of heart disease and stroke. Approximately 95% of all diagnosed cases of diabetes in adults are type 2 diabetes (T2DM).* Recent guideline changes and newly available therapies have made it ever more challenging for the PCP to confidently assist their patients in staying ahead of disease progression.[i] Clinical inertia and uncertainty lead to poor glycemic control.**

 

*Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012. Available at: www.cdc.gov/diabetes/pubs/pdf/DiabetesReportCard.pdf.  Accessed June 20, 2016.
**Inzucchi, SE,  Bergenstal, RM,  Buse, JB,  Diamant, Ferrannini, E, Nauck, M, Peters, A, Tsapas, A, Wender, R, Matthews, D Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach - Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care.  2012; 35 (6): 1364-1379. 
 

Target Audience

Physicians, physician assistants, NPs, and other allied healthcare professionals. 

Objectives

Part 1-Using Non-insulin Agents

At the completion of this module the learner will:

  1. Identify the 12 classes of diabetes medications
  2. Explain how non-insulin agents address the main pathophysiologic defects of T2DM
  3. Recognize the benefits and risks of the newer non-insulin agents for T2DM: DPP-4 inhibitors, GLP-1 RAs and SGLT-2 inhibitors
  4. Apply knowledge of metabolic staging of T2DM to initiate and advance therapy, particularly with the newer non-insulin agents 

Part 2- Using Insulin

At the completion of this module the learner will:

  1. List circumstances when insulin should be started in T2DM
  2. Recognize the action profiles and dosing strategies of commonly used insulins
  3. Initiate and advance insulin therapy in T2DM
  4. Comfortably practice the combined use of basal and prandial insulins

Faculty Disclosure

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Speaker:

Elliot Sternthal, MD, FACP, FACE
Dr. Sternthal has no relevant financial relationships to disclose. 
Faculty member does not plan to discuss unlabeled/investigational uses of a commercial product.

Planning Committee:

Jason Worcester, MD

Program Managers

Emma Trucks, MPH
Emily Jansen, MPH

Members of the planning committee have no relevant financial relationships to disclose.

 

DISCLAIMER

THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.